ArticleBioinformatics (Oxford, England)2025
ReAlign-P: a vertical iterative realignment method for protein multiple sequence alignment.
Article in Bioinformatics (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A comprehensive toolkit for analyzing cell-free DNA genomic sequencing data in liquid biopsy.iScience · 2026Article
- Advances in post-processing methods for multiple sequence alignment.Frontiers in genetics · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
motivationReliable protein multiple sequence alignment (MSA) is essential for downstream biomedical research and directly impacts the accuracy of analytical results. However, protein sequences often exhibit low similarity and complex alignment patterns, and existing general alignment tools frequently fall short in terms of accuracy. Many current realignment methods are outdated, suffering from issues such as code obsolescence and inadequate precision. As a result, there is a pressing need for realignment methods that can better address these challenges.
resultsThis study introduces ReAlign-P, a realignment tool designed specifically for protein MSA. ReAlign-P first divides the initial alignment into three regions and applies a novel vertical iterative realignment strategy to optimize the more conserved middle region. This method is by default compatible with MUSCLE5 for realignment, leading to a significant improvement in accuracy. We evaluated initial alignments generated using 10 different MSA parameter configurations across four protein benchmark datasets. The results demonstrate that ReAlign-P consistently outperforms or matches the quality of the initial alignments in all cases. In contrast, RASCAL-the only other currently functional protein realignment tool-sometimes even reduces alignment quality. ReAlign-P not only delivers more substantial improvements but also exhibits greater stability, effectively addressing the gap in available protein realignment tools. AVAILABILITY AND IMPLEMENTATION: The source code and test data for ReAlign-P are available on GitHub (https://github.com/malabz/ReAlign-P).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.